Neumora Therapeutics (NMRA) Shares Outstanding (Diluted) (2022 - 2026)
Neumora Therapeutics (NMRA) recorded Shares Outstanding (Diluted) of 185.16 million in Q2 2026, up 14.5% from 161.69 million a year earlier and up 2.9% from the prior quarter.
Neumora Therapeutics (NMRA) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Neumora Therapeutics reported Shares Outstanding (Diluted) of 163.39 million, up 2.5% from FY2024.
- Annual Shares Outstanding (Diluted) has increased for three straight years, with a three-year compound annual growth rate of 81.8% (FY2022 to FY2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 159.38 million in FY2024 (+145.1%), 65.02 million in FY2023 (+139.0%) and 27.21 million in FY2022.
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to Q3 2022.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased for 12 consecutive quarters, with growth averaging 52.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 1.4% in Q3 2025 to 439.5% in Q1 2024.
- Per Business Quant, the preceding three quarters came in at 179.87 million (Q1 2026), 163.39 million (Q4 2025) and 161.84 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Neumora Therapeutics | 112.74 Mn | 112.74 Mn | - | 185.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 185.16 Mn |
| Mar 31, 2026 | 179.87 Mn |
| Dec 31, 2025 | 163.39 Mn |
| Sep 30, 2025 | 161.84 Mn |
| Jun 30, 2025 | 161.69 Mn |
| Mar 31, 2025 | 161.45 Mn |
| Dec 31, 2024 | 159.38 Mn |
| Sep 30, 2024 | 159.58 Mn |
| Jun 30, 2024 | 158.98 Mn |
| Mar 31, 2024 | 157.94 Mn |
| Dec 31, 2023 | 65.02 Mn |
| Sep 30, 2023 | 46.69 Mn |
| Jun 30, 2023 | 30.13 Mn |
| Mar 31, 2023 | 29.28 Mn |
| Dec 31, 2022 | 27.21 Mn |
| Sep 30, 2022 | 27.65 Mn |
Neumora Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NMRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();